Medicine and Dentistry
Infection
100%
Positron Emission Tomography
81%
Mycobacterium Tuberculosis
51%
Molecular Imaging
43%
Severe Acute Respiratory Syndrome Coronavirus 2
36%
Disease
35%
Fluorine-18
34%
Tuberculous Meningitis
28%
Lung Tuberculosis
28%
Tuberculosis Treatment
26%
Carbon 11
25%
Toddlers
23%
Pathogen
20%
Antibiotics
20%
Tuberculosis
20%
COVID-19
20%
Bacterial Infection
20%
Radioactive Tracer
17%
Macrophage
17%
Granuloma
17%
Single-Photon Emission Computed Tomography
15%
Fluorodeoxyglucose F 18
15%
Diagnosis
15%
Computer Assisted Tomography
15%
Antiinfective Agent
14%
Positron Emission Tomography-Computed Tomography
14%
Pharmacokinetics
14%
Rifampicin
14%
Pediatrics
14%
Necrosis
14%
Antibiotic Therapy
12%
Iodine 125
12%
4 Aminobenzoic Acid
12%
Positron Emission Tomography
11%
Neoplasm
11%
Staphylococcus Aureus
11%
Clinical Trial
10%
Lung Lesion
10%
Tumor Necrosis Factor
9%
Biological Marker
9%
Bactericidal Activity
9%
Matrix Metalloproteinase
9%
Extensively Drug Resistant Tuberculosis
9%
Nuclear Medicine
9%
Fever of Unknown Origin
9%
Central Nervous System Tuberculosis
8%
In Vitro
8%
Meningitis
8%
Biodistribution
7%
Lung Cavitation
7%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
81%
Mycobacterium Tuberculosis
73%
Mouse
58%
Disease
50%
Fluorine 18
40%
Tuberculous Meningitis
37%
Mouse Model
36%
Rifampicin
33%
Tracer
29%
Carbon 11
26%
Antiinfective Agent
23%
Inflammation
23%
SARS Coronavirus
22%
Infectious Agent
22%
Biodistribution
21%
Pharmacokinetics
19%
Antibiotics
18%
Granuloma
16%
Central Nervous System Tuberculosis
16%
Bacterial Infection
15%
4-Aminobenzoic Acid
15%
Antibiotic Agent
15%
Linezolid
15%
Lung Tuberculosis
14%
HIV
14%
Clinical Trial
13%
Meningitis
13%
Lung Lesion
13%
Necrosis
12%
Rabbit Model
11%
Staphylococcus Aureus
11%
Tuberculoma
11%
C3HeB/Fe Mouse
10%
Tuberculosis
10%
Syrian Hamster
10%
Coronavirinae
10%
Extensively Drug-Resistant Tuberculosis
9%
Abscess
9%
Human Study
9%
Radiopharmaceutical Agent
9%
Sorbitol
9%
Rifapentine
9%
Pretomanid
9%
Drug Resistance
7%
Iodine-125
7%
Tuberculin
7%
Bacilli
7%
Recurrence Risk
6%
Streptococcus Pneumoniae
6%
Prevalence
6%
Keyphrases
Tuberculosis
72%
Positron Emission Tomography
63%
Mycobacterium Tuberculosis (M. tb)
51%
Bacterial Infection
29%
Molecular Imaging
28%
Tuberculous Meningitis
24%
Mouse Model
23%
Tuberculosis Treatment
22%
Infected Mice
22%
Lung
21%
Antibiotics
20%
COVID-19
18%
Murine Model
18%
DPA-713
18%
4-aminobenzoic Acid
18%
Macrophages
17%
Pulmonary Tuberculosis
16%
India
16%
Pharmacokinetics
15%
Rifampin
15%
Young children
14%
Infectious Diseases
14%
124I
13%
Antimicrobial
13%
Biodistribution
13%
Single-photon Emission Computed Tomography (SPECT)
12%
Inflammation
11%
Bioimaging
11%
Radiosynthesis
11%
PET Radiotracers
10%
Linezolid
10%
Cavitation
10%
Cavitary Tuberculosis
9%
Dynamic Positron Emission Tomography
9%
Imaging Tools
9%
Imaging Approach
9%
Positron Emission Tomography-computed Tomography (PET-CT)
9%
125I
9%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
9%
High Dose
9%
Radiopharmaceuticals
9%
Latent Tuberculosis Infection
9%
Sorbitol
9%
Aerosol
8%
Radiotracer
8%
Novel Therapeutics
8%
Intralesional
8%
In Situ
8%
Computed Tomography
8%
Clinical Translation
7%